Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.90    -0.20 (-9.52%)
Bid:
1.80
Ask:
1.975
Spread: 0.175 (9.722%)
Market Cap: £38.12m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Directorate Change

20 Sep 2010 07:00

RNS Number : 9254S
Quintain Estates & Development PLC
20 September 2010
 



 

20 September 2010

 

Quintain Estates & Development plc

("Quintain" / "Company" / "Group")

 

Directorate Change

 

QUINTAIN STRENGTHENS BOARD WITH NEW NON EXECUTIVE DIRECTOR

 

Christopher Bell appointed Senior Independent Director

 

Quintain Estates & Development plc announces the appointment of Christopher Bell as Non Executive Director, with immediate effect. Chris will become a member of the Audit, Remuneration and Nomination Committees and immediately assume the role of Senior Independent Director of the Board, a role made vacant by David Pangbourne's retirement, which was announced on 3 June 2010.

 

Age 52, Chris joined Hilton Group plc in 1991, becoming Managing Director of its Ladbrokes Worldwide business in 1995 and a board member of Hilton in 2000. Following the sale of the hotels division in 2006, Chris became Chief Executive of the stand alone FTSE 100 Company, Ladbrokes plc, which he led until April 2010.

 

He is currently Senior Non Executive Director of FTSE 250 retailer, The GAME Group, a position he has held since 2003, and is also on the Board of the Responsible Gambling Strategy Board, which advises the Gambling Commission and the Government on policy and strategy in this field.

 

William Rucker, Chairman of Quintain, said:

"Christopher's considerable corporate experience and detailed understanding of the retail and leisure sectors will be of great benefit to Quintain, which has extensive retail and entertainment interests at both its major regeneration schemes. I am delighted to welcome him to the Board and look forward to working with him as Quintain proceeds to deliver the milestones crucial to the fulfilment of the 2013 business plan."

 

Aside from the information set out in the announcement above, no further information is required to be disclosed pursuant to Listing Rule 9.6.13R.

 

 

 

 

For further information, please contact:

 

Quintain Estates & Development plc

Rebecca Worthington / Cressida Curtis

Tel: +44 (0) 20 7495 8968

 

Financial Dynamics

Stephanie Highett / Dido Laurimore / Laurence Jones

Tel: +44 (0) 20 7831 3113

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALLFFRADIDLII
Date   Source Headline
1st Aug 20247:00 amRNSValkor Project Update
10th Jul 20247:00 amRNSMarine Project Update
26th Jun 20247:00 amRNSExtended agreement with BTG Bioliquids for bioMSAR
29th May 20247:00 amRNSRepresentation Agreement Addendum & Warrants Grant
28th May 20247:00 amRNSOCP Commercial Framework Agreement
2nd May 20247:00 amRNSQuadrise-Vertoro JDA to sea-trial bioMSAR Zero
29th Apr 20247:00 amRNSMarine Project Update
19th Apr 20247:00 amRNSValkor Project Update
12th Apr 20244:58 pmRNSResults of Open Offer
22nd Mar 20243:10 pmRNSExtension of Open Offer Closing Date
20th Mar 20241:01 pmRNSInvestor Presentation
19th Mar 20247:00 amRNSPlacing Results, Open Offer & Posting of Circular
18th Mar 20244:55 pmRNSProposed Placing, Subscription and Open Offer
18th Mar 20244:53 pmRNSInterim Results
15th Feb 20247:00 amRNSAgreement with Euthenia & BTG Bioliquids
6th Feb 20247:00 amRNSMarine Project Update
6th Dec 20237:00 amRNSUpdate re bioMSARâ„¢ and bioMSARâ„¢ Zero Development
27th Nov 20235:46 pmRNSResult of AGM
27th Nov 20237:00 amRNSAGM Statement
22nd Nov 20237:00 amRNSMorocco Project Update
9th Nov 20237:00 amRNSPublication of 2023 Sustainability Report
31st Oct 202312:45 pmRNSMorocco Project Update
27th Oct 20234:20 pmRNSPosting of Annual Report & Notice of AGM
24th Oct 20239:33 amRNSChange of Nominated Adviser
2nd Oct 20237:30 amRNSDirectorate Change
2nd Oct 20237:00 amRNSFinal Results and Notice of AGM
12th Sep 20237:00 amRNSMorocco Project Update
29th Aug 20237:00 amRNSValkor Project Update
24th Aug 202312:29 pmRNSValkor Update
18th Aug 20233:46 pmRNSMorocco Update
4th Aug 20237:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 20234:15 pmRNSDirector/PDMR Shareholding
28th Jul 20234:25 pmRNSDirector/PDMR Shareholding
25th Jul 20233:34 pmRNSResults of Open Offer
7th Jul 202312:00 pmRNSInvestor Presentation
7th Jul 202310:38 amRNSPlacing Results, Open Offer & Posting of Circular
7th Jul 20237:00 amRNSProposed Placing and Open Offer
22nd Jun 20237:00 amRNSMorocco Update
12th Jun 20237:00 amRNSValkor Site License & Supply Agreement
8th Jun 20237:00 amRNSJoint Development Agreement with BTG Bioliquids
26th May 20237:00 amRNSVertoro Joint Development Agreement Update
22nd May 20237:00 amRNSMorocco Update
16th May 20234:29 pmRNSReplacement: Business Update
16th May 20237:00 amRNSBusiness Update
25th Apr 20237:00 amRNSAppointment of Joint Broker
29th Mar 20237:00 amRNSInterim Results
28th Mar 20237:00 amRNSChange of Company Name
22nd Oct 20155:26 pmRNSDelisting of Quintain ordinary shares
15th Oct 20154:30 pmRNSHolding(s) in Company
15th Oct 20154:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.